The company is a medical devices company that has developed a novel therapeutic approach for ablation of solid tumors in cancer patients. The technology uses Auroshell nano-particles that are inert material particles that absorb and convert laser energy into heat. The particles are delivered to patients systemically, and an interstitial fiber optic probe is subsequently used to deliver laser energy to indicated sites destroying tumors without damaging adjacent tissue. This technology avoids the systemic toxicity of traditional chemotherapy, and is poised to serve as adjunct in cancer treatments.
The Cancer Consortium
Cancer News & Information Center
